✦ LIBER ✦

Replacement of angiotensin converting enzyme inhibition by carvedilol results in long-term reversed left ventricular remodeling in mild heart failure and is well tolerated: Results of the CARMEN (Carvedilol aceinhibitor remodeling in mild heart failure evaluation) study

✍ Scribed by Willem J. Remme; Jordi Soler-Soler; Lars Ryden; Per Hildebrandt; Marco Bobbio; Wybren Jaarsma; Michel Komajda; Armin Scherhag; Guenther Riegger

Book ID: 119546908
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 210 KB
Volume: 41
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(03)81543-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carvedilol treatment is as well tolerate

Carvedilol treatment is as well tolerated as angiotensin converting enzyme inhibition in patients with chronic heart failure: Results of the CARMEN (Carvedilol ACE inhibitor remodeling mild CHF evaluation) study

✍ Michel Komajda; Hugo Madeira; Kristian Thygesen; Marco Bobbio; Wybren Jaarsma; G 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 191 KB

Do patients necessarily have to start wi

Do patients necessarily have to start with an angiotension converting enzyme inhibitor in the treatment of heart failure? Results of the CARMEN (Carvedilol ACE Inhibitor Remodeling Mild CHF Evaluation) study

✍ Willem J. Remme; Guenther Riegger; Per Hildebrandt; Michel Komajda; Marco Bobbio 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Long-term impact of cardiac resynchroniz

Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study

✍ Linde, C.; Gold, M. R.; Abraham, W. T.; St John Sutton, M.; Ghio, S.; Cerkvenik, 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 342 KB